Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)

v2.4.0.8
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
 3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Revenue:        
PCT products, services, other $ 196,522 $ 224,384 $ 418,092 $ 389,156
Grant revenue 161,214 100,524 310,382 241,413
Total revenue 357,736 324,908 728,474 630,569
Costs and expenses:        
Cost of PCT products and services 83,829 109,203 188,373 187,397
Research and development 260,408 256,307 506,866 527,918
Selling and marketing 188,392 168,173 382,292 406,265
General and administrative 683,133 474,015 1,233,992 1,156,361
Total operating costs and expenses 1,215,762 1,007,698 2,311,523 2,277,941
Operating loss (858,026) (682,790) (1,583,049) (1,647,372)
Other (expense) income:        
Interest (expense) income,net (63,110) (4,214) (72,013) (60,527)
Other (expense) (208,709)    (208,709)   
Change in fair value of derivative liability 63,804 177,312 18,359 135,300
Total other (expense) income (208,015) 173,098 (262,363) 74,773
Net loss (1,066,041) (509,692) (1,845,410) (1,572,599)
Accrued and deemed dividends on convertible preferred stock (107,871) (579,974) (722,592) (604,388)
Net loss applicable to common shareholders $ (1,173,912) $ (1,089,666) $ (2,568,002) $ (2,176,987)
Net loss per share attributable to common stockholders - basic and diluted $ (0.10) $ (0.11) $ (0.22) $ (0.21)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 11,521,794 10,197,850 11,883,797 10,352,461